Disease | hyperthermia |
Comorbidity | C0376545|hematological malignancies |
Sentences | 16 |
PubMedID- 22111760 | Bacteria and fungi are the major etiological agents of chemotherapy induced febrile neutropenia in patients with hematological malignancies [1,2]. |
PubMedID- 24164924 | The identification of risk factors and outcomes of vre bsi is necessary for establishing strategies for managing neutropenic fever in patients with hematological malignancies. |
PubMedID- 26124158 | Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignancies. |
PubMedID- 24642872 | For example, fever in patients with hematological malignancies may depend on infection, lysis of malignant cells, and/or chemotherapy-induced mucosal damage. |
PubMedID- 20882524 | Micafungin is safe and effective for the empirical antifungal therapy of febrile neutropenia in patients with hematological malignancies. |
PubMedID- 23372683 | Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. |
PubMedID- 23668467 | Antimicrobial agent prescription patterns for chemotherapy-induced febrile neutropenia in patients with hematological malignancies at sultan qaboos university hospital, oman. |
PubMedID- 22978686 | Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies. |
PubMedID- 26295293 | This study aimed to investigate fungal agents in febrile neutropenic patients with hematological malignancies. |
PubMedID- 25587291 | Conclusion: micafungin has similar efficacy to caspofungin as empirical antifungal therapy in febrile neutropenic patients with hematological malignancies. |
PubMedID- 25152113 | Conclusion: itraconazole injection was an effective and safe agent in targeted and diagnostic- driven antifungal therapy for immunocompromised or neutropenic febrile patients with hematological malignancies. |
PubMedID- 23317527 | Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies. |
PubMedID- 20227988 | Hema e-chart: italian registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies. |
PubMedID- 20807030 | We investigated mold colonization of air handling units (ahus) of heating, ventilating, and air conditioning (hvac) systems and its effects, including invasive pulmonary mycoses and febrile neutropenia, in patients with hematological malignancies. |
PubMedID- 20471883 | Cefepime-resistant gram-negative bacteremia in febrile neutropenic patients with hematological malignancies. |
PubMedID- 20662227 | [optimal administration of antimicrobial agents for febrile neutropenia in patients with hematological malignancies]. |
Page: 1